Authors:
Raymond, E
Faivre, S
Weiss, G
McGill, J
Davidson, K
Izbicka, E
Kuhn, JG
Allred, C
Clark, GM
Von Hoff, DD
Citation: E. Raymond et al., Effects of hydroxyurea on extrachromosomal DNA in patients with advanced ovarian carcinomas, CLIN CANC R, 7(5), 2001, pp. 1171-1180
Authors:
Faivre, S
Raymond, E
Boige, V
Gatineau, M
Buthaut, X
Rixe, O
Bernareggi, A
Camboni, G
Armand, JP
Citation: S. Faivre et al., A phase I and pharmacokinetic study of the novel aza-anthracenedione compound BBR 2778 in patients with advanced solid malignancies, CLIN CANC R, 7(1), 2001, pp. 43-50
Citation: P. Goin et E. Raymond, Redeeming a postmining landscape (Eagle Mountain mine in the Mojave Desertof Riverside County, California), J ARCHIT ED, 54(3), 2001, pp. 195-197
Authors:
Delaloge, S
Yovine, A
Taamma, A
Riofrio, M
Brain, E
Raymond, E
Cottu, P
Goldwasser, F
Jimeno, J
Misset, JL
Marty, M
Cvitkovic, E
Citation: S. Delaloge et al., Ecteinascidin-743: A marine-derived compound in advanced, pretreated sarcoma patients - Preliminary evidence of activity, J CL ONCOL, 19(5), 2001, pp. 1248-1255
Citation: P. Goin et E. Raymond, Living in anthracite: Mining landscape and sense of place in Wyoming Valley, Pennsylvania, PUBLIC HIST, 23(2), 2001, pp. 29-45
Authors:
Hennequin, C
Salemkour, A
Mal, F
Lecomte, T
Boudet, MJ
Perniceni, T
Gayet, B
Maylin, C
Raymond, E
Citation: C. Hennequin et al., Chemotherapy with cisplatinum, carboplatin and 5FU-folinic acid, followed by concomitant chemo-radiotherapy in unresectable esophageal carcinomas, B CANCER, 88(2), 2001, pp. 203-207
Authors:
Pivot, X
Raymond, E
Laguerre, B
Degardin, M
Cals, L
Armand, JP
Lefebvre, JL
Gedouin, D
Ripoche, V
Kayitalire, L
Niyikiza, C
Johnson, R
Latz, J
Schneider, M
Citation: X. Pivot et al., Pemetrexed disodium in recurrent locally advanced or metastatic squamous cell carcinoma of the head and neck, BR J CANC, 85(5), 2001, pp. 649-655
Authors:
Louvet, C
Coudray, AM
Tournigand, C
Prevost, S
Raymond, E
de Gramont, A
Chazard, M
Gespach, C
Citation: C. Louvet et al., Synergistic antitumoral activity of combined UFT, folinic acid and oxaliplatin against human colorectal HT29 cell xenografts in athymic nude mice, ANTI-CANC D, 11(7), 2000, pp. 579-582
Authors:
Delord, JP
Raymond, E
Chaouche, M
Ruffie, P
Ducreux, M
Faivre, S
Boige, V
Le Chevalier, T
Rixe, O
Baudin, E
Pautier, P
Rodier, JM
Chouaki, N
Escudier, B
Kayitalire, L
Armand, JP
Citation: Jp. Delord et al., A dose-finding study of gemcitabine and vinorelbine in advanced previouslytreated malignancies, ANN ONCOL, 11(1), 2000, pp. 73-79
Citation: V. Ribrag et E. Raymond, The concept of time in delivering a medication: the case of anticancer agents, M S-MED SCI, 16(4), 2000, pp. 513-518
Authors:
Andre, F
Raymond, E
Doubre, H
Le Chevalier, T
Armand, JP
Citation: F. Andre et al., Cell targets of new drugs and results of new chemotherapy schemes in non-small-cell lung cancer., REV MAL RES, 17(1), 2000, pp. 417-424
Authors:
Boige, V
Raymond, E
Faivre, S
Gatineau, M
Meely, K
Mekhaldi, S
Pautier, P
Ducreux, M
Rixe, O
Armand, JP
Citation: V. Boige et al., Phase I and pharmacokinetic study of the camptothecin analog DX-8951f administered as a 30-minute infusion every 3 weeks in patients with advanced cancer, J CL ONCOL, 18(23), 2000, pp. 3986-3992
Authors:
Soda, H
Raymond, E
Sharma, S
Lawrence, R
Davidson, K
Oka, M
Kohno, S
Izbicka, E
Von Hoff, DD
Citation: H. Soda et al., Effects of androgens on telomerase activity in normal and malignant prostate cells in vitro, PROSTATE, 43(3), 2000, pp. 161-168
Authors:
Raymond, E
Soria, JC
Izbicka, E
Boussin, F
Hurley, L
Von Hoff, DD
Citation: E. Raymond et al., DNA G-quadruplexes, telomere-specific proteins and telomere-associated enzymes as potential targets for new anticancer drugs, INV NEW DR, 18(2), 2000, pp. 123-137
Authors:
Disler, DG
Raymond, E
May, DA
Wayne, JS
McCauley, TR
Citation: Dg. Disler et al., Articular cartilage defects: In vitro evaluation of accuracy and interobserver reliability for detection and grading with US, RADIOLOGY, 215(3), 2000, pp. 846-851
Authors:
Rowinsky, E
Raymond, E
Ciardiello, F
Averbuch, SD
Citation: E. Rowinsky et al., Epidermal growth factor receptor-targeted approaches for anticancer therapy: Focus on ZD1839 - Questions and answers, DRUGS, 60, 2000, pp. 41-42